{"id":8630,"date":"2023-01-13T10:01:38","date_gmt":"2023-01-13T09:01:38","guid":{"rendered":"https:\/\/semmelweis.hu\/bioinformatika\/?page_id=8630"},"modified":"2024-04-25T12:07:38","modified_gmt":"2024-04-25T10:07:38","slug":"2020-ban-megjelent-publikaciok","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/bioinformatika\/publikaciok\/2020-ban-megjelent-publikaciok\/","title":{"rendered":"2020-ban megjelent publik\u00e1ci\u00f3ink"},"content":{"rendered":"

1: Menyh\u00e1rt O, Gy\u0151rffy B.<\/strong> Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches. Cancer Metastasis Rev. 2020 Mar;39(1):211-233. doi: 10.1007\/s10555-020-09854-1. PMID: 31970590; PMCID: PMC7098941.<\/p>\n

2: Fekete JT,<\/strong> Welker \u00c1, Gy\u0151rffy B.<\/strong> miRNA Expression Signatures of Therapy Response in Squamous Cell Carcinomas. Cancers (Basel). 2020 Dec 28;13(1):63. doi: 10.3390\/cancers13010063. PMID: 33379285; PMCID: PMC7794682.<\/p>\n

3: Wong CK, Lambert AW, Ozturk S, Papageorgis P, Lopez D, Shen N, Sen Z, Abdolmaleky HM, Gy\u0151rffy B<\/strong>, Feng H, Thiagalingam S. Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. Mol Cancer Res. 2020 Mar;18(3):414-423. doi: 10.1158\/1541-7786.MCR-19-0525. Epub 2020 Jan 13. PMID: 31932471; PMCID: PMC7115128.<\/p>\n

4: Awah CU, Chen L, Bansal M, Mahajan A, Winter J, Lad M, Warnke L, Gonzalez- Buendia E, Park C, Zhang D, Feldstein E, Yu D, Zannikou M, Balyasnikova IV, Martuscello R, Konerman S, Gy\u0151rffy B<\/strong>, Burdett KB, Scholtens DM, Stupp R, Ahmed A, Hsu P, Sonabend AM. Ribosomal protein S11 influences glioma response to TOP2 poisons. Oncogene. 2020 Jul;39(27):5068-5081. doi: 10.1038\/s41388-020-1342-0. Epub 2020 Jun 11. PMID: 32528131; PMCID: PMC7646677.<\/p>\n

5: Zhu L, Hissa B, Gy\u0151rffy B<\/strong>, Jann JC, Yang C, Reissfelder C, Sch\u00f6lch S. Characterization of Stem-like Circulating Tumor Cells in Pancreatic Cancer. Diagnostics (Basel). 2020 May 15;10(5):305. doi: 10.3390\/diagnostics10050305. PMID: 32429174; PMCID: PMC7278018.<\/p>\n

6: El-Balat A, Karn T, Holtrich U, Becker S, Kommoss S, Gy\u0151rffy B<\/strong>, Anglesio MS, Huntsman DG, Drosos Z, Rody A, Gevensleben H, Hanker LC. Histotype-specific
\nanalysis of acid ceramidase expression in ovarian cancer. Virchows Arch. 2020 Jun;476(6):855-862. doi: 10.1007\/s00428-019-02728-0. Epub 2020 Jan 2. PMID: 31897818.<\/p>\n

7: Nagy \u00c1, Pongor S, Gy\u0151rffy B<\/strong>. Different mutations in SARS-CoV-2 associate with severe and mild outcome. Int J Antimicrob Agents. 2021 Feb;57(2):106272. doi:
\n10.1016\/j.ijantimicag.2020.106272. Epub 2020 Dec 23. PMID: 33347989; PMCID: PMC7755579.<\/p>\n

8: Ai C, Zhang J, Lian S, Ma J, Gy\u0151rffy B<\/strong>, Qian Z, Han Y, Feng Q. FOXM1 functions collaboratively with PLAU to promote gastric cancer progression. J Cancer. 2020 Jan 1;11(4):788-794. doi: 10.7150\/jca.37323. PMID: 31949481; PMCID: PMC6959008.<\/p>\n

9: P\u00e1link\u00e1s HL, B\u00e9k\u00e9si A, R\u00f3na G, Pongor L, Papp G, Tihanyi G, Holub E, P\u00f3ti \u00c1, Gemma C, Ali S, Morten MJ, Rothenberg E, Pagano M, Sz\u0171ts D, Gy\u0151rffy B<\/strong>, V\u00e9rtessy
\nBG. Genome-wide alterations of uracil distribution patterns in human DNA upon chemotherapeutic treatments. Elife. 2020 Sep 21;9:e60498. doi: 10.7554\/eLife.60498. PMID: 32956035; PMCID: PMC7505663.<\/p>\n

10: Zhu L, Kan KJ, Gr\u00fcn JL, Hissa B, Yang C, Gy\u0151rffy B<\/strong>, Loges S, Rei\u00dffelder C, Sch\u00f6lch S. GAS2L1 Is a Potential Biomarker of Circulating Tumor Cells in Pancreatic Cancer. Cancers (Basel). 2020 Dec 15;12(12):3774. doi: 10.3390\/cancers12123774. PMID: 33333841; PMCID: PMC7765300.<\/p>\n

11: Periyasamy M, Singh AK, Gemma C, Farzan R, Allsopp RC, Shaw JA, Charmsaz S, Young LS, Cunnea P, Coombes RC, Gy\u0151rffy B<\/strong>, Buluwela L, Ali S. Induction of
\nAPOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-\u03baB. Oncogene. 2021 Feb;40(6):1077-1090. doi: 10.1038\/s41388-020-01583-7. Epub 2020 Dec 15. PMID: 33323971; PMCID: PMC7116738.<\/p>\n

12: Baster Z, Li L, Kukkurainen S, Chen J, Pentik\u00e4inen O, Gy\u0151rffy B<\/strong>, Hyt\u00f6nen VP, Zhu H, Rajfur Z, Huang C. Cyanidin-3-glucoside binds to talin and modulates colon cancer cell adhesions and 3D growth. FASEB J. 2020 Feb;34(2):2227-2237. doi: 10.1096\/fj.201900945R. Epub 2020 Jan 9. PMID: 31916632.<\/p>\n

13: Augimeri G, La Camera G, Gelsomino L, Giordano C, Panza S, Sisci D, Morelli C, Gy\u0151rffy B<\/strong>, Bonofiglio D, And\u00f2 S, Barone I, Catalano S. Evidence for Enhanced Exosome Production in Aromatase Inhibitor-Resistant Breast Cancer Cells. Int J Mol Sci. 2020 Aug 14;21(16):5841. doi: 10.3390\/ijms21165841. PMID: 32823947; PMCID: PMC7461508.<\/p>\n

14: Shafran JS, Jafari N, Casey AN, Gy\u0151rffy B<\/strong>, Denis GV. BRD4 regulates key transcription factors that drive epithelial-mesenchymal transition in castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2021 Mar;24(1):268-277. doi: 10.1038\/s41391-020-0246-y. Epub 2020 Jul 21. PMID: 32690869; PMCID: PMC7855805.<\/p>\n

15: Nagy \u00c1, Gy\u0151rffy B<\/strong>. muTarget: A platform linking gene expression changes and mutation status in solid tumors. Int J Cancer. 2021 Jan 15;148(2):502-511. doi: 10.1002\/ijc.33283. Epub 2020 Sep 17. PMID: 32875562.<\/p>\n

16: Fernandez AI, Geng X, Chaldekas K, Harris B, Duttargi A, Berry VL, Berry DL, Mahajan A, Cavalli LR, Gy\u0151rffy B<\/strong>, Tan M, Riggins RB. The orphan nuclear receptor
\nestrogen-related receptor beta (ERR\u03b2) in triple-negative breast cancer. Breast Cancer Res Treat. 2020 Feb;179(3):585-604. doi: 10.1007\/s10549-019-05485-5. Epub 2019 Nov 19. PMID: 31741180; PMCID: PMC7153462.<\/p>\n

17: Matsuyama T, Kandimalla R, Ishikawa T, Takahashi N, Yamada Y, Yasuno M, Kinugasa Y, Hansen TF, Fakih M, Uetake H, Gy\u0151rffy B<\/strong>, Goel A. A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer. Int J Cancer. 2020 Dec 1;147(11):3250-3261. doi: 10.1002\/ijc.33129. Epub 2020 Jul 13. PMID: 32657428; PMCID: PMC9192151.<\/p>\n

18: Fan JB, Miyauchi S, Xu HZ, Liu D, Kim LJY, Burkart C, Cheng H, Arimoto KI, Yan M, Zhou Y, Gy\u0151rffy B<\/strong>, Knobeloch KP, Rich JN, Cang H, Fu XD, Zhang DE. Type I Interferon Regulates a Coordinated Gene Network to Enhance Cytotoxic T Cell- Mediated Tumor Killing. Cancer Discov. 2020 Mar;10(3):382-393. doi: 10.1158\/2159-8290.CD-19-0608. Epub 2020 Jan 23. PMID: 31974171; PMCID: PMC7058499.<\/p>\n

19: Pongor LS, Munk\u00e1csy G<\/strong>, Vereczkey I, Pete I, Gy\u0151rffy B<\/strong>. Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting. Sci Rep. 2020 Sep 1;10(1):14403. doi: 10.1038\/s41598-020-71382-3. PMID: 32873813; PMCID: PMC7463012.<\/p>\n

20: Donini CF, El Helou M, Wierinckx A, Gy\u0151rffy B<\/strong>, Aires S, Escande A, Croze S, Clezardin P, Lachuer J, Diab-Assaf M, Ghayad SE, Fervers B, Cavaill\u00e8s V, Maguer- Satta V, Cohen PA. Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo[a]pyrene and\/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR\/GPR30 Interplay. Front Oncol. 2020 May 29;10:712. doi: 10.3389\/fonc.2020.00712. PMID: 32670863; PMCID: PMC7326103.<\/p>\n

21: Abdel-Fatah TMA, Ball GR, Thangavelu PU, Reid LE, McCart Reed AE, Saunus JM, Duijf PHG, Simpson PT, Lakhani SR, Pongor L, Gyorffy B<\/strong>, Moseley PM, Green AR, Pockley AG, Caldas C, Ellis IO, Chan SYT. Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor-Positive Breast Cancer. JAMA Netw Open. 2020 Jul 1;3(7):e209486. doi: 10.1001\/jamanetworkopen.2020.9486. PMID: 32633764; PMCID: PMC7341179.<\/p>\n

22: Sawada Y, Kikugawa T, Iio H, Sakakibara I, Yoshida S, Ikedo A, Yanagihara Y, Saeki N, Gy\u0151rffy B<\/strong>, Kishida T, Okubo Y, Nakamura Y, Miyagi Y, Saika T, Imai Y. GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer. Int J Cancer. 2020 Mar 1;146(5):1369-1382. doi: 10.1002\/ijc.32554. Epub 2019 Jul 22. PMID: 31276604.<\/p>\n

23: Fekete JT<\/strong>, \u0150sz \u00c1, Pete I, Nagy GR, Vereczkey I, Gy\u0151rffy B<\/strong>. Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients. Gynecol Oncol. 2020 Mar;156(3):654-661. doi: 10.1016\/j.ygyno.2020.01.006. Epub 2020 Jan 20. PMID: 31973910.<\/p>\n

24: Serrano-Oviedo L, Nuncia-Cantarero M, Morcillo-Garcia S, Nieto-Jimenez C, Burgos M, Corrales-Sanchez V, Perez-Pe\u00f1a J, Gy\u0151rffy B<\/strong>, Oca\u00f1a A, Gal\u00e1n-Moya EM. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer. Cell Oncol (Dordr). 2020 Jun;43(3):431-444. doi: 10.1007\/s13402-020-00497-6. Epub 2020 Mar 12. PMID: 32166583; PMCID: PMC7214516.<\/p>\n

25: Hargadon KM, Gy\u0151rffy B<\/strong>, McGee TJ. Genomic and transcriptional changes in IFN\u03b3 pathway genes are putative biomarkers of response to ipilimumab immunotherapy in melanoma patients. Expert Rev Clin Immunol. 2020 Dec;16(12):1099-1103. doi: 10.1080\/1744666X.2021.1847644. Epub 2020 Nov 15. PMID: 33151785.<\/p>\n

26: Kim SJ, Ju JS, Kang MH, Eun JW, Kim YH, Raninga PV, Khanna KK, Gy\u0151rffy B<\/strong>, Pack CG, Han HD, Lee HJ, Gong G, Shin Y, Mills GB, Eyun SI, Park YY. RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC. Theranostics. 2020 Jul 2;10(18):7974-7992. doi: 10.7150\/thno.45037. PMID: 32724453; PMCID: PMC7381744.<\/p>\n

27: Cimas FJ, Manzano A, Baliu-Piqu\u00e9 M, Garc\u00eda-Gil E, P\u00e9rez-Segura P, Nagy \u00c1<\/strong>, Pandiella A, Gy\u0151rffy B<\/strong>, Ocana A. Genomic Mapping Identifies Mutations in RYR2 and AHNAK as Associated with Favorable Outcome in Basal-Like Breast Tumors Expressing PD1\/PD-L1. Cancers (Basel). 2020 Aug 11;12(8):2243. doi: 10.3390\/cancers12082243. PMID: 32796628; PMCID: PMC7464853.<\/p>\n

28: Hassan N, Rutsch N, Gy\u0151rffy B<\/strong>, Espinoza-S\u00e1nchez NA, G\u00f6tte M. SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells. Sci Rep. 2020 Feb 10;10(1):2262. doi: 10.1038\/s41598-020-59057-5. PMID: 32042016; PMCID: PMC7010743.<\/p>\n

29: Alcaraz-Sanabria A, Baliu-Piqu\u00e9 M, Saiz-Ladera C, Rojas K, Manzano A, Marquina G, Casado A, Cimas FJ, P\u00e9rez-Segura P, Pandiella A, Gyorffy B<\/strong>, Ocana A. Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors. Front Oncol. 2020 Jan 10;9:1486. doi: 10.3389\/fonc.2019.01486. PMID: 31998644; PMCID: PMC6965148.<\/p>\n

30: R\u00f6del F, Zhou S, Gy\u0151rffy B<\/strong>, Raab M, Sanhaji M, Mandal R, Martin D, Becker S, Strebhardt K. The Prognostic Relevance of the Proliferation Markers Ki-67 and Plk1 in Early-Stage Ovarian Cancer Patients With Serous, Low-Grade Carcinoma Based on mRNA and Protein Expression. Front Oncol. 2020 Oct 7;10:558932. doi: 10.3389\/fonc.2020.558932. PMID: 33117692; PMCID: PMC7577119.<\/p>\n","protected":false},"excerpt":{"rendered":"

1: Menyh\u00e1rt O, Gy\u0151rffy B. Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches. Cancer Metastasis Rev. 2020 Mar;39(1):211-233. doi: 10.1007\/s10555-020-09854-1. PMID: 31970590; PMCID: PMC7098941. 2: Fekete JT, Welker \u00c1, Gy\u0151rffy B. miRNA Expression Signatures of Therapy Response in Squamous Cell Carcinomas. Cancers (Basel). 2020 Dec 28;13(1):63. doi: 10.3390\/cancers13010063. PMID: 33379285; …<\/p>\n","protected":false},"author":102018,"featured_media":0,"parent":8610,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-8630","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages\/8630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/users\/102018"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/comments?post=8630"}],"version-history":[{"count":10,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages\/8630\/revisions"}],"predecessor-version":[{"id":10240,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages\/8630\/revisions\/10240"}],"up":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/pages\/8610"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/media?parent=8630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/categories?post=8630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/bioinformatika\/wp-json\/wp\/v2\/tags?post=8630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}